MEDICAMEN BIOTECH
|
The Current P/E Ratio of MEDICAMEN BIOTECH is 65.68.
| Share Price | ₹352.2 | Oct 28,2025 |
| Market Cap | ₹479.0 Cr | |
| Earnings-TTM | ₹7.3 Cr | TTM-Consolidated Results |
| Price/Earnings | 65.68x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of MEDICAMEN BIOTECH
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹479.0 Cr] as on Oct 28,2025
(/) Earnings [ ₹7.3 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 65.68x ]
Thus, for MEDICAMEN BIOTECH , the investors are currently willing to pay 65.68 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of MEDICAMEN BIOTECH !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of MEDICAMEN BIOTECH over the last five years.
Historical PE (Price/Earnings) ratio chart of MEDICAMEN BIOTECH
PE Ratio Performance Analysis for MEDICAMEN BIOTECH
- MEDICAMEN BIOTECH 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 61.52x.
- MEDICAMEN BIOTECH 's operated at median p/e ratio of 53.78x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, MEDICAMEN BIOTECH 's p/e ratio peaked in Mar2025 at 93.43x.
- MEDICAMEN BIOTECH 's p/e ratio hit its five-year low in Mar2024 of 51.31x.
How does MEDICAMEN BIOTECH 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| MEDICAMEN BIOTECH | 7.29 | 65.68 | 479.0 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 10,411.50 | 38.88 | 404,804.0 |
| DIVIS LABORATORIES LTD | 2,306.00 | 74.05 | 170,764.0 |
| CIPLA LTD | 5,406.81 | 23.45 | 126,807.0 |
| TORRENT PHARMACEUTICALS LTD | 2,002.00 | 60.49 | 121,099.0 |
| DR REDDYS LABORATORIES LTD | 5,721.40 | 18.83 | 107,707.0 |
| MANKIND PHARMA LTD | 1,905.51 | 52.09 | 99,256.0 |
| ZYDUS LIFESCIENCES LTD | 4,637.80 | 21.73 | 100,759.0 |
| LUPIN LTD | 3,722.18 | 23.58 | 87,750.6 |
| AUROBINDO PHARMA LTD | 3,417.93 | 18.68 | 63,862.0 |
| ABBOTT INDIA LTD | 1,452.29 | 43.60 | 63,319.4 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs MEDICAMEN BIOTECH 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 18.68x |
| Max industry PE | 74.05x |
| Median industry PE | 38.88x |
| Average industry PE | 40.10x |
You may also like the below Video Courses